Mar 17, 2023
Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Danielle Brander and Craig Moskowitz on recent advances and real-world implications in chronic lymphocytic leukemia and lymphomas.
Mar 2, 2023
Featuring perspectives from Dr Matthew Lunning, including the following topics:
• Potential role of polatuzumab vedotin/R-CHP in therapy for previously untreated diffuse large B-cell lymphoma (DLBCL) (00:00)
• Association between metabolic tumor volume and clinical outcomes with loncastuximab tesirine in...
Feb 23, 2023
Featuring perspectives from Drs Farrukh Awan and Kelly Rogers, including the following topics:
• Case: A woman in her early 90s with underlying chronic obstructive pulmonary disease was observed for 20 years for chronic lymphocytic leukemia (CLL) before initiating treatment with acalabrutinib and quickly...
Feb 18, 2023
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 2: Follicular Lymphoma and Mantle Cell Lymphoma — Dr Laurie Sehn
Feb 18, 2023
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 1: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Dr Christopher Flowers